Skip to main content
Log in

ASO Visual Abstract: Adjuvant Therapy for Patients with a Tumor-Positive Resection Margin After Neoadjuvant Chemoradiotherapy and Esophagectomy

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Acknowledgement

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Charlène J. van der Zijden MD.

Ethics declarations

Disclosure

B.M. received research funding from Sanofi, Pfizer, and BMS and provided consultancy/advisory services for Lilly, Servier, BMS, Amgen, and AstraZeneca; B.P.L.W. received research funding from BMS and provided consultancy/advisory services for BMS; all remaining authors declare that they have no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

van der Zijden, C.J., van der Sluis, P.C., Mostert, B. et al. ASO Visual Abstract: Adjuvant Therapy for Patients with a Tumor-Positive Resection Margin After Neoadjuvant Chemoradiotherapy and Esophagectomy. Ann Surg Oncol (2024). https://doi.org/10.1245/s10434-024-15044-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1245/s10434-024-15044-y

Navigation